Table 1.

Demographics and baseline clinical characteristics.

	Intervention	Control	P-Value
Sex, n (%)Male Female	20 (51.3) 19 (48.7)	19 (50) 19 (50)	0.910
Age,year mean (SD)	35.4 (9)	33.2 (8.5)	0.675
BMImean (SD)	25.28 (4.22)	24.22 (4.14)	0.560
Blood Group N(%)O + A+	15 (45.5) 14 (42.4)	20 (57.1) 4 (11.4)
B+	1 (3)	6 (17.1)
B-	2 (6.1)	1 (2.9)
AB	1 (3)	2 (5.7)
Medical history
Smoking, n (%)	1 (2.6)	0	1.000
Asthma, n (%)	1 (2.6)	0
DM, n (%)	1 (2.6)	0
HTN, n (%)	1 (2.6)	1 (2.6)	1.000
DLP, n (%)	0	1 (2.6)	1.000
Thyroid disorder, n (%)	1 (2.6)	3 (7.9)	0.358
Sinusitis, n (%)	4 (10.3)	1 (5.3)	0.675
Depression, n (%)	0	1 (2.6)
Baseline clinical symptoms
Cough, n (%)	7 (17.9)	7 (18.4)	0.957
Sore throat, n (%)	12 (30.8)	6 (15.8)	0.120
Fever, n (%)	22 (56.4)	17 (44.7)	0.306
Chills, n (%)	13 (33.3)	13 (34.2)	0.935
Dyspnea, n (%)	1 (2.6)	3 (7.9)	0.292
Fatigue, n (%)	14 (35.9)	14 (36.8)	0.931
Runny nose, n (%)	7 (17.9)	1 (2.6)	0.056
Loss of appetite, n (%)	2 (5.1)	1 (2.6)	1.000
Phantosmia, n (%)	0	1 (2.6)	0.494
Chest pain, n (%)	0	1 (2.6)	0.494
Headache, n (%)	13 (33.3)	23 (60.5)	0.017
Myalgia, n (%)	25 (64.1)	20 (52.6)	0.307
Exacerbation of sinusitis, n (%)	4 (10.3)	2 (5.3)	0.414
Vomiting, n (%)	1 (2.6)	2 (5.3)	0.615
Diarrhea, n (%)	2 (5.1)	2 (5.3)	1.000
Decreased sense of hearing, n (%)	0	1 (2.6)	0.494
Vertigo, n (%)	0	1 (2.6)	0.494
Nasal burning, n (%)	2 (5.1)	2 (5.3)	1.000
Nasal congestion, n (%)	12 (30.8)	6 (15.8)	0.120
Ageusia, n (%)	31 (79.5)	31 (81.6)	0.817

SD: Standard Deviation, BMI: Body Mass Area, DM: Diabetes Mellitus, HTN: Hypertension, DLP: Dyslipidemia.